Table 2.
Glioma survival in relation to recent pre-diagnostic body weight
| BMI (Kg/m2)* | Age-Adjusted Models** | Multivariable Models† | ||||
|---|---|---|---|---|---|---|
| Number | Deaths | AHR (95% CI) | Number | Deaths | AHR (95% CI) | |
| Overall | ||||||
| <18.5 | 13 | 9 | 2.02 (1.03, 3.96) | 11 | 7 | 1.28 (0.60, 2.77) |
| 18.5– 24.9 | 251 | 164 | referent | 206 | 136 | referent |
| 25–29.9 | 348 | 251 | 1.04 (0.85, 1.27) | 300 | 221 | 1.16 (0.93, 1.45) |
| ≥30 | 241 | 181 | 1.24 (1.00, 1.54) | 195 | 143 | 1.32 (1.04, 1.68) |
| Males | ||||||
| <18.5 | 5 | 4 | 2.48 (0.90, 6.84) | 5 | 4 | 2.03 (0.73, 5.68) |
| 18.5–24.9 | 99 | 69 | referent | 83 | 59 | referent |
| 25–29.9 | 243 | 182 | 1.10 (0.84, 1.46) | 212 | 162 | 1.30 (0.96, 1.77) |
| ≥30 | 159 | 122 | 1.30 (0.97, 1.75) | 128 | 96 | 1.45 (1.04, 2.03) |
| Females | ||||||
| <18.5 | 8 | 5 | 1.70 (0.69, 4.20) | 6 | 3 | 1.06 (0.32, 3.50) |
| 18.5–24.9 | 152 | 95 | referent | 123 | 77 | referent |
| 25–29.9 | 105 | 69 | 0.96 (0.70, 1.31) | 88 | 59 | 1.01 (0.71, 1.42) |
| ≥30 | 82 | 59 | 1.25 (0.91, 1.74) | 67 | 47 | 1.29 (0.89, 1.87) |
*
BMI (body mass index) 1 year (N=103) or 5 years (N=750) prior to glioma diagnosis
**
Hazard ratio (HR) and 95% confidence interval (CI) adjusted for age and in overall model, gender
†
Hazard ratio (HR) and 95% confidence interval (CI) adjusted for age, KPS, treatment, and in overall model, gender.
Abbreviations: BMI (body mass index); AHR (Adjusted Hazards Ratio); CI (Confidence Interval). Unequal cell counts comparing age-adjusted and multivariate models reflect missing data.